Fragile X syndrome (FXS) is the most common inherited cause of autism and intellectual disabilities worldwide.
FRAXA Research Foundation is working to find specific treatments and ultimately a cure for Fragile X, but at present, there is no cure. Most males and many females with Fragile X syndrome are significantly affected throughout their lives. The cost to society for treatment, special education, and lost income is staggering. The need for research aimed at treatment is urgent.
Fragile X syndrome is a genetic disorder that occurs when a single gene on the X chromosome shuts down. This gene makes a protein needed for normal brain development. In FXS it does not work properly, the protein is not made, and the brain does not develop as it should.
FXS can affect both sexes. Females generally have milder symptoms than males, although there is a lot of variation and no good way to predict this. While most males have intellectual impairment, only one-third of females have significant intellectual challenges. The rest have either normal IQ or learning disabilities. Math is often a particular challenge for females. Emotional and behavioral problems are common in both sexes.
Both boys and girls may have delays in learning how to speak, but most individuals with Fragile X are verbal. Lifespan for people with Fragile X syndrome is generally normal. Many affected people have active lifestyles and good health.
- Intellectual disabilities, ranging from mild to severe.
- Attention deficit and hyperactivity, especially in young children.
- Anxiety and unstable mood.
- Autistic behaviors, such as hand-flapping and not making eye contact.
- Sensory integration problems, such as hypersensitivity to loud noises or bright lights.
- Speech delay, with expressive language more severely affected than receptive language.
- Seizures (epilepsy) affect about 25% of people with Fragile X syndrome.
These features may be hard to recognize in babies and young children, but sometimes become more apparent with age. Not everyone with Fragile X has all these signs.
- Long face, large prominent ears, flat feet.
- Hyperextensible joints, especially fingers.
- Low muscle tone.
- Males may have large testes after puberty.
Fragile X Prevalence and Inheritance
Sources do not agree on the prevalence of Fragile X syndrome, but recent estimates suggest 1 in 4,000 males and 1 in 8,000 females have FXS.
The Fragile X premutation can be passed silently down through generations in a family before a child is born with the syndrome.
- Women who carry Fragile X have a 50% chance of passing the mutated gene to each of her children. If she passes the affected gene, her children will either be carriers or they will have Fragile X syndrome.
- Men who carry Fragile X will pass the premutation to all their daughters but none of their sons. These daughters are carriers but they do not have Fragile X syndrome.
Fragile X and Autism
About 46% of males and 16% with Fragile X meet full criteria for autism, according to the CDC. Most boys and some girls have some symptoms of autism, but many tend to be very social and interested in other people. The key difference between the two disorders is that Fragile X is diagnosed by blood test and autism is diagnosed by assessing behaviors.
There are many helpful educational and behavioral strategies, as well as Occupational Therapy (OT), Physical Therapy (PT), and Speech Therapy (PT), to help. An extensive array of medications is available to manage symptoms.
FRAXA-funded research has achieved significant breakthroughs, bringing us closer to finding new treatments.
There is hope.
We know that the Fragile X protein’s normal role is to help shape the connections between neurons (brain cells) that underlie learning and memory. Because absence of FMR protein delays the development of neurons, rather than destroying them, it is likely that treatments now being investigated will benefit all individuals with Fragile X, regardless of age.
- Fragile X Clinics and Clinical Trial Sites offers a map view of Fragile X clinics around the US and highlights those that participate in clinical trials.
- Fragile X Clinical Trials are happening now around the US and beyond. FRAXA is funding trials of new and available medications. You or your family member may be able to join a study and help move this critical work forward. At the same time, other teams are working to turn the FMR1 gene back on to cure Fragile X.
- Medication Guide for Fragile X Syndrome, by Dr. Michael Tranfaglia, FRAXA Medical Director and Chief Scientific Officer, provides background information to help parents, caretakers and others to communicate with their physicians.
- In February 2020, Dr. Tranfaglia shared his Favorite Combination of Available Drugs to Treat Fragile X.
- Early Intervention is recommended for children ages 0-3. Early intervention provides family services to help the child and family address developmental delays.
- During school years, most children benefit from an Individualized Education Plan (IEP). Speech, occupational, and physical therapy can also help.
- FRAXA produced this presentation and slide series for teachers and therapists working in the classroom with young children who have Fragile X.
Learn from Parents
- The Fragile X Guide for Parents by Parents is chock full of tips, stories and strategies from parents.
- FRAXA Ambassadors are volunteers who represent FRAXA Research Foundation in their communities. Our ambassadors are leaders who help us share the latest information about Fragile X syndrome and research to find effective treatments and ultimately a cure.
- If you’re on Facebook, you might enjoy the parent-run Fragile X group with over 8,000 members.
- #FriendofFRAXA highlights anyone touched by Fragile X, including friends, grandparents, siblings, professionals and companions alike.